Buyback yield (TTM)
2.09%
Shareholder yield (TTM)
2.09%
5Y share count change
0.5%
Buyback spend (TTM)
$3.42B
Cumulative buybacks
$11.25B
Key takeaways
- Intuitive Surgical (ISRG) repurchased about $3.42B of stock over the trailing twelve months.
- Diluted share count is roughly flat (0.5%) over the last ~5 fiscal years — buybacks are offsetting dilution but not shrinking the float.
- TTM buyback ÷ stock-based-comp ratio of 4.21× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +76.4% per year over the latest 5-year window.
- TTM repurchases used about 121% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Intuitive Surgical (ISRG)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Intuitive Surgical (ISRG)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Intuitive Surgical (ISRG)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Intuitive Surgical (ISRG)
Latest: $2.30B
Overview
Intuitive Surgical (ISRG) most recent annual buyback spend stands at $2.30B (2025).
Intuitive Surgical buyback spend compound annual growth for the 2020–2025 (5 years) window is +76.4%, with mixed annual results across the window.
Intuitive Surgical buyback spend peaked at $2.61B in 2022; the latest annual figure is $2.30B in 2025 (12.0% below peak).
The record annual buyback spend stands at $2.61B, reached in 2022; the historical low of $0.00 was recorded in 2004.
Intuitive Surgical Buyback Spend 2025: $2.30B
Intuitive Surgical buyback spend in 2025 was $2.30B.
Intuitive Surgical Buyback Spend 2024: $0.00
In 2024, Intuitive Surgical reported buyback spend of $0.00, plunged 100.0% below 2023.
Intuitive Surgical Buyback Spend 2023: $416.30M
Intuitive Surgical buyback spend in 2023 was $416.30M, plunged 84.0% below 2022.
Intuitive Surgical Buyback Spend 2022: $2.61B
Intuitive Surgical buyback spend in 2022 was $2.61B.
Intuitive Surgical Buyback Spend 2021: $0.00
Intuitive Surgical buyback spend in 2021 was $0.00.
See more financial history for Intuitive Surgical (ISRG).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $2.30B | $788.20M | $1.51B | 1.14% | 0.36B | +0.2% | |
| 2024 | $0.00 | $676.80M | −$676.80M | — | 0.36B | +1.3% | |
| 2023 | $416.30M | $598.20M | −$181.90M | 0.35% | 0.36B | -1.3% | |
| 2022 | $2.61B | $513.20M | $2.09B | 2.80% | 0.36B | -1.0% | |
| 2021 | $0.00 | $449.20M | −$449.20M | — | 0.37B | +1.4% | |
| 2020 | $134.30M | $395.40M | −$261.10M | 0.14% | 0.36B | +0.7% | |
| 2019 | $269.50M | $335.80M | −$66.30M | 0.39% | 0.36B | +0.6% | |
| 2018 | $0.00 | $261.20M | −$261.20M | — | 0.36B | +2.1% | |
| 2017 | $2.27B | $209.10M | $2.06B | 5.55% | 0.35B | -1.4% | |
| 2016 | $42.50M | $177.60M | −$135.10M | 0.17% | 0.35B | +3.7% | |
| 2015 | $183.70M | $167.90M | $15.80M | 0.90% | 0.34B | +0.5% | |
| 2014 | $1.00B | $168.90M | $831.10M | 5.21% | 0.34B | -6.0% | |
| 2013 | $1.11B | $168.90M | $940.30M | 7.45% | 0.36B | -2.4% | |
| 2012 | $238.30M | $153.30M | $85.00M | 1.21% | 0.37B | +2.2% | |
| 2011 | $331.80M | $136.40M | $195.40M | 1.83% | 0.36B | -0.2% | |
| 2010 | $198.60M | $117.60M | $81.00M | 1.97% | 0.36B | +2.8% | |
| 2009 | $150.00M | $96.98M | $53.02M | 1.29% | 0.35B | -1.8% | |
| 2008 | $0.00 | $0.00 | $0.00 | — | 0.36B | +2.4% | |
| 2007 | $0.00 | $36.29M | −$36.29M | — | 0.35B | +2.4% | |
| 2006 | $0.00 | $25.26M | −$25.26M | — | 0.34B | +1.6% | |
| 2005 | $72.00K | $4.75M | −$4.68M | 0.00% | 0.34B | +7.2% | |
| 2004 | $0.00 | $0.00 | $0.00 | — | 0.31B | +48.0% | |
| 2003 | $6.00K | $700.00K | −$694.00K | 0.00% | 0.21B | +29.6% | |
| 2002 | $2.00K | $2.57M | −$2.57M | 0.00% | 0.16B | +1.8% | |
| 2001 | $65.00K | $0.00 | $65.00K | 0.02% | 0.16B | +50.5% | |
| 2000 | $20.00K | $0.00 | $20.00K | — | 0.11B | +391.9% | |
| 1999 | $43.00K | $0.00 | $43.00K | — | 0.02B | — |
- 2025$2.30B
- 2024$0.00
- 2023$416.30M
- 2022$2.61B
- 2021$0.00
- 2020$134.30M
- 2019$269.50M
- 2018$0.00
- 2017$2.27B
- 2016$42.50M
- 2015$183.70M
- 2014$1.00B
- 2013$1.11B
- 2012$238.30M
- 2011$331.80M
- 2010$198.60M
- 2009$150.00M
- 2008$0.00
- 2007$0.00
- 2006$0.00
- 2005$72.00K
- 2004$0.00
- 2003$6.00K
- 2002$2.00K
- 2001$65.00K
- 2000$20.00K
- 1999$43.00K
Buybacks vs stock-based compensation for Intuitive Surgical (ISRG)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 4.21×.
Buybacks vs dividends (share of cash returned) for Intuitive Surgical (ISRG)
How Intuitive Surgical splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Intuitive Surgical, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $2.83B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation